Literature DB >> 1579806

HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis.

V Taneja1, N K Mehra, A N Chandershekaran, R K Ahuja, Y N Singh, A N Malaviya.   

Abstract

The distribution of HLA class II antigens in the Asian Indian patients with rheumatoid arthritis (RA) was studied in the present investigation. The results demonstrated that DR4 was significantly increased in both northern (chi 2 = 36.9, P less than 0.00001) as well as southern Indian (chi 2 = 17.3, P less than 0.0001) patients. HLA haplotype analysis revealed the presence of B17-DR4 among southern Indians. Amongst northern Indians, four DR4 haplotypes occurred significantly: A1,B17,DR4; A19,B7, DR4; A30,B13,DR4; and A33,B44,DR4. An analysis of TA10 and DQ'Wa' specificities revealed that all the DR4-DQw3 positive northern Indian RA patients were DQw8 as compared to its frequency of 33.3% in controls. A positive association observed between DR4-DQw7 and RA in some western Caucasian populations was not present in this series. A group of three DR4 positive RA patients were found to be DQw3 negative and DQ'Wa' or DQw4 positive. These results indicated that susceptibility to RA may be controlled by genes in the DR locus independent of any DQ associations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579806     DOI: 10.1007/bf00301502

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  33 in total

Review 1.  Autoimmune diseases and HLA.

Authors:  J L Nelson; J A Hansen
Journal:  Crit Rev Immunol       Date:  1990       Impact factor: 2.214

Review 2.  Nomenclature for factors of the HLA system, 1989.

Authors:  J G Bodmer; S G Marsh; E Albert
Journal:  Immunol Today       Date:  1990-01

3.  HLA-DR antigens in rheumatoid arthritis in North India.

Authors:  N K Nehra; M C Vaidya; V Taneja; A Agarwal; A N Malaviya
Journal:  Tissue Antigens       Date:  1982-10

4.  PCR-SSO typing in HLA-disease association studies.

Authors:  P Wordsworth
Journal:  Eur J Immunogenet       Date:  1991 Feb-Apr

5.  Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis.

Authors:  N J Olsen; L F Callahan; R H Brooks; E P Nance; J J Kaye; P Stastny; T Pincus
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

6.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.

Authors:  B Schiff; Y Mizrachi; S Orgad; M Yaron; E Gazit
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  Immunogenetics of rheumatoid arthritis in Israel.

Authors:  C Brautbar; Y Naparstek; M Yaron; A Amar; M Ehrenfeld; M Eliakim; Z Bentwich; T Cohen; S H Korman; E D Albert
Journal:  Tissue Antigens       Date:  1986-07

8.  New HLA DNA polymorphisms associated with rheumatoid arthritis.

Authors:  S D Cutbush; W Ollier; J Awad; H L Currey; H Festenstein
Journal:  Dis Markers       Date:  1986-06       Impact factor: 3.434

9.  HLA-D antigen of Japanese origin (LD-Wa) and its association with Vogt-Koyanagi-Harada syndrome.

Authors:  H Yakura; A Wakisaka; M Aizawa; K Itakura; Y Tagawa
Journal:  Tissue Antigens       Date:  1976-07

10.  HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritis.

Authors:  J Ilonen; H Reijonen; H Arvilommi; I Jokinen; T Möttönen; P Hannonen
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

View more
  12 in total

Review 1.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Immune response to immunodominant Mycobacterium tuberculosis antigen ESAT-6 derived peptide is HLA-haplotype dependent.

Authors:  Michele Smart; Marshall Behrens; Luckey David; Catherine Conway; Veena Taneja
Journal:  Jacobs J Allergy Immunol       Date:  2014-09-05

Review 3.  B cells as effectors and regulators of sex-biased arthritis.

Authors:  David Luckey; Kay Medina; Veena Taneja
Journal:  Autoimmunity       Date:  2012-08       Impact factor: 2.815

Review 4.  To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.

Authors:  Marshall Behrens; Michele Smart; David Luckey; Harvinder Luthra; Veena Taneja
Journal:  J Autoimmun       Date:  2011-06-12       Impact factor: 7.094

5.  HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis.

Authors:  D S Bradley; G H Nabozny; S Cheng; P Zhou; M M Griffiths; H S Luthra; C S David
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis.

Authors:  E Zanelli; C J Krco; J M Baisch; S Cheng; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice.

Authors:  Marshall Behrens; George K Papadopoulos; Antonis Moustakas; Michele Smart; Harvinder Luthra; Chella S David; Veena Taneja
Journal:  Arthritis Rheum       Date:  2011-06

8.  Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis.

Authors:  Veena Taneja; Marshall Behrens; Eati Basal; Josh Sparks; Marie M Griffiths; Harvinder Luthra; Chella S David
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice.

Authors:  Marshall Behrens; Theodore Trejo; Harvinder Luthra; Marie Griffiths; Chella S David; Veena Taneja
Journal:  J Autoimmun       Date:  2010-01-12       Impact factor: 7.094

10.  CD74/DQA1 dimers predispose to the development of arthritis in humanized mice.

Authors:  Luckey David; Ameya Gokhale; Seetharama Jois; Aaron Johnson; Marshall Behrens; Harvinder Luthra; Veena Taneja
Journal:  Immunology       Date:  2015-12-21       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.